150 related articles for article (PubMed ID: 34095848)
1. Investigation of thiazolyl-benzothiophenamides as potential agents for African sleeping sickness.
Brown RW; Abdel-Megeed AM; Keller PA; Jones AJ; Sykes ML; Kaiser M; Baell JB; Avery VM; Hyland CJT
RSC Med Chem; 2020 Dec; 11(12):1413-1422. PubMed ID: 34095848
[TBL] [Abstract][Full Text] [Related]
2. Comparative analysis of cerebrospinal fluid from the meningo-encephalitic stage of T. b. gambiense and rhodesiense sleeping sickness patients using TMT quantitative proteomics.
Tiberti N; Sanchez JC
Data Brief; 2015 Sep; 4():400-5. PubMed ID: 26306311
[TBL] [Abstract][Full Text] [Related]
3. Chemotherapeutic strategies against Trypanosoma brucei: drug targets vs. drug targeting.
Lüscher A; de Koning HP; Mäser P
Curr Pharm Des; 2007; 13(6):555-67. PubMed ID: 17346174
[TBL] [Abstract][Full Text] [Related]
4. Priorities for the elimination of sleeping sickness.
Welburn SC; Maudlin I
Adv Parasitol; 2012; 79():299-337. PubMed ID: 22726645
[TBL] [Abstract][Full Text] [Related]
5. The origins of a new Trypanosoma brucei rhodesiense sleeping sickness outbreak in eastern Uganda.
Fèvre EM; Coleman PG; Odiit M; Magona JW; Welburn SC; Woolhouse ME
Lancet; 2001 Aug; 358(9282):625-8. PubMed ID: 11530149
[TBL] [Abstract][Full Text] [Related]
6. The role of cytokines in the pathogenesis and staging of Trypanosoma brucei rhodesiense sleeping sickness.
Kato CD; Matovu E; Mugasa CM; Nanteza A; Alibu VP
Allergy Asthma Clin Immunol; 2016; 12():4. PubMed ID: 26807135
[TBL] [Abstract][Full Text] [Related]
7. Update on human African trypanosomiasis (sleeping sickness).
Kennedy PGE
J Neurol; 2019 Sep; 266(9):2334-2337. PubMed ID: 31209574
[TBL] [Abstract][Full Text] [Related]
8. Evaluating the impact of targeting livestock for the prevention of human and animal trypanosomiasis, at village level, in districts newly affected with T. b. rhodesiense in Uganda.
Hamill L; Picozzi K; Fyfe J; von Wissmann B; Wastling S; Wardrop N; Selby R; Acup CA; Bardosh KL; Muhanguzi D; Kabasa JD; Waiswa C; Welburn SC
Infect Dis Poverty; 2017 Feb; 6(1):16. PubMed ID: 28162093
[TBL] [Abstract][Full Text] [Related]
9. Trypanosomosis agglutination card test for Trypanosoma brucei rhodesiense sleeping sickness.
Akol MN; Olaho-Mukani W; Odiit M; Enyaru JC; Matovu E; Magona J; Okitoi ND
East Afr Med J; 1999 Jan; 76(1):38-41. PubMed ID: 10442147
[TBL] [Abstract][Full Text] [Related]
10. 3-(Oxazolo[4,5-b]pyridin-2-yl)anilides as a novel class of potent inhibitors for the kinetoplastid Trypanosoma brucei, the causative agent for human African trypanosomiasis.
Ferrins L; Rahmani R; Sykes ML; Jones AJ; Avery VM; Teston E; Almohaywi B; Yin J; Smith J; Hyland C; White KL; Ryan E; Campbell M; Charman SA; Kaiser M; Baell JB
Eur J Med Chem; 2013 Aug; 66():450-65. PubMed ID: 23831695
[TBL] [Abstract][Full Text] [Related]
11. Sleeping Sickness in the 'Omics Era.
Tiberti N; Sanchez JC
Proteomics Clin Appl; 2018 Jul; 12(4):e1700041. PubMed ID: 29517161
[TBL] [Abstract][Full Text] [Related]
12. Development of drug resistance in Trypanosoma brucei rhodesiense and Trypanosoma brucei gambiense. Treatment of human African trypanosomiasis with natural products (Review).
Gehrig S; Efferth T
Int J Mol Med; 2008 Oct; 22(4):411-9. PubMed ID: 18813846
[TBL] [Abstract][Full Text] [Related]
13. The Production of
Özbilgin A; Çavuş İ; Nuraydın A; Özel Y
Turkiye Parazitol Derg; 2020 Mar; 44(1):7-11. PubMed ID: 32212582
[TBL] [Abstract][Full Text] [Related]
14. Human African trypanosomiasis.
Lejon V; Bentivoglio M; Franco JR
Handb Clin Neurol; 2013; 114():169-81. PubMed ID: 23829907
[TBL] [Abstract][Full Text] [Related]
15. A multiplex PCR that discriminates between Trypanosoma brucei brucei and zoonotic T. b. rhodesiense.
Picozzi K; Carrington M; Welburn SC
Exp Parasitol; 2008 Jan; 118(1):41-6. PubMed ID: 17643434
[TBL] [Abstract][Full Text] [Related]
16. Anti-Trypanosomatid Elemanolide Sesquiterpene Lactones from Vernonia lasiopus O. Hoffm.
Kimani NM; Matasyoh JC; Kaiser M; Brun R; Schmidt TJ
Molecules; 2017 Apr; 22(4):. PubMed ID: 28397756
[TBL] [Abstract][Full Text] [Related]
17. An alternative form of melarsoprol in sleeping sickness.
Kennedy PG
Trends Parasitol; 2012 Aug; 28(8):307-10. PubMed ID: 22704910
[TBL] [Abstract][Full Text] [Related]
18. Genetic diversity and population structure of Trypanosoma brucei in Uganda: implications for the epidemiology of sleeping sickness and Nagana.
Echodu R; Sistrom M; Bateta R; Murilla G; Okedi L; Aksoy S; Enyioha C; Enyaru J; Opiyo E; Gibson W; Caccone A
PLoS Negl Trop Dis; 2015 Feb; 9(2):e0003353. PubMed ID: 25695634
[TBL] [Abstract][Full Text] [Related]
19. Trypanosoma brucei infection in a HIV positive Ugandan male.
Dill EA; Renault C; Kirkpatrick BD
Clin Lab Sci; 2011; 24(2):85-8. PubMed ID: 21657140
[TBL] [Abstract][Full Text] [Related]
20. Evidence for the occurrence of Trypanosoma brucei rhodesiense sleeping sickness outside the traditional focus in south-eastern Uganda.
Enyaru JC; Odiit M; Winyi-Kaboyo R; Sebikali CG; Matovu E; Okitoi D; Olaho-Mukani W
Ann Trop Med Parasitol; 1999 Dec; 93(8):817-22. PubMed ID: 10715675
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
